[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359159-105":59,"doc-detail-359159-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","breast-cancer-surgery-in-the-era-of-genetic-uncertainty-real-world-outcomes-in-brca12-pathogenic-variants-and-variants-of-uncertain-significance","Breast cancer surgery in the era of genetic uncertainty - real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance","","Germline BRCA1 and BRCA2 testing guides breast cancer surgery, but increasing identification of variants of uncertain significance (VUS) creates clinical uncertainty about cancer risk and treatment implications. This multicenter retrospective study evaluated real-world surgical management patterns (2017–2025) across three institutions in Türkiye, focusing on determinants of final bilateral mastectomy. Among 203 patients, final bilateral mastectomy was far more common in pathogenic carriers than VUS carriers, with age also independently associated.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-surgery-in-the-era-of-genetic-uncertainty-real-world-outcomes-in-brca12-pathogenic-variants-and-variants-of-uncertain-significance/359159/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-surgery-in-the-era-of-genetic-uncertainty-real-world-outcomes-in-brca12-pathogenic-variants-and-variants-of-uncertain-significance/359159.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What clinical challenge does the paper address regarding BRCA testing?","Question",{"text":113,"@type":114},"The paper addresses how variants of uncertain significance (VUS) complicate clinical management because their implications for cancer risk and treatment remain unclear.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was final bilateral mastectomy defined in the study?",{"text":118,"@type":114},"Final bilateral mastectomy included either primary bilateral mastectomy or unilateral mastectomy followed by completion contralateral mastectomy.",{"name":120,"@type":111,"acceptedAnswer":121},"What factors were associated with final bilateral mastectomy among pathogenic BRCA carriers?",{"text":122,"@type":114},"Pathogenic BRCA status was independently associated with final bilateral mastectomy, and increasing age also showed an independent association.",{"name":124,"@type":111,"acceptedAnswer":125},"What influenced surgical decision-making among VUS carriers?",{"text":126,"@type":114},"In the VUS subgroup, clinicopathological variables were not significantly associated with final bilateral mastectomy, and younger age at diagnosis emerged as the only independent factor in exploratory multivariable modeling.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},359159,1790374718,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":46,"preview_page_count":19,"preview_urls":149},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Ökten et al. BMC Cancer (2026) 26:383 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15721-z](https://doi.org/10.1186/s12885-026-15721-z)  \nRESEARCH Open Access  \nBreast cancer surgery in the era of genetic  uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance  \nIlker Nihat Ökten1*, Tuba Baydaş1, Sinan Koca1, Mukaddes Feyza Baltacı2, Filiz Özen2, İbrahim Çil3, Metin Eser4, Adnan Gündoğdu5, Merve Aktaş6 and Osman CemYılmaz7  \nAbstract  \nBackground Germline testing for BRCA1 and BRCA2 has become integral to the management of breast cancer, with pathogenic variants strongly influencing surgical decision-making. However, the increasing detection of variants of uncertain significance (VUS) presents a major clinical challenge, as their implications for cancer risk and treatment remain unclear. This study aimed to evaluate real-world surgical management patterns among breast cancer patients carrying pathogenic BRCA1/2 variants or VUS, with a particular focus on determinants of final bilateral mastectomy. Methods This multicenter retrospective study included female breast cancer patients who underwent germline BRCA1/2 testing across three institutions inTürkiye between 2017 and 2025. Patients carrying pathogenic variants or VUS were identified and reclassified according to American College of Medical Genetics and Genomics (ACMG) criteria. Clinicopathological characteristics and surgical outcomes were compared between pathogenic and VUS groups. Final bilateral mastectomy was defined as either primary bilateral mastectomy or unilateral mastectomy followed by completion contralateral mastectomy. Multivariable logistic regression was performed to identify factors independently associated with final bilateral mastectomy, including a separate exploratory analysis restricted to VUS carriers.  \nResults A total of 203 patients with abnormal BRCA results were included, comprising 107 pathogenic variant carriers and 96 VUS carriers. Patients with pathogenic BRCA variants were significantly younger at diagnosis and more frequently had triple-negative tumors. Final bilateral mastectomy was markedly more common among pathogenic variant carriers than VUS carriers (67% vs. 12%, p \u003C 0. 001) . In multivariable analysis, pathogenic BRCA status remained independently associated with final bilateral mastectomy (adjusted OR 10. 38, 95% CI 3.98–27. 10; p \u003C 0. 001), while increasing age was also independently associated.  \nAmong VUS carriers, no clinicopathological variable—including molecular subtype, tumor size, Ki-67 index, family history, or BRCA1 versus BRCA2 VUS—was significantly associated with final bilateral mastectomy in univariate  \n*Correspondence: Ilker Nihat Ökten [ilkernihat@gmail.com](ilkernihat@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc","cbCaimwUAZxVRMwT","https://ap.wps.com/l/cbCaimwUAZxVRMwT","pdf",1556806,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What clinical challenge does the paper address regarding BRCA testing?\",\"answer\":\"The paper addresses how variants of uncertain significance (VUS) complicate clinical management because their implications for cancer risk and treatment remain unclear.\"},{\"question\":\"How was final bilateral mastectomy defined in the study?\",\"answer\":\"Final bilateral mastectomy included either primary bilateral mastectomy or unilateral mastectomy followed by completion contralateral mastectomy.\"},{\"question\":\"What factors were associated with final bilateral mastectomy among pathogenic BRCA carriers?\",\"answer\":\"Pathogenic BRCA status was independently associated with final bilateral mastectomy, and increasing age also showed an independent association.\"},{\"question\":\"What influenced surgical decision-making among VUS carriers?\",\"answer\":\"In the VUS subgroup, clinicopathological variables were not significantly associated with final bilateral mastectomy, and younger age at diagnosis emerged as the only independent factor in exploratory multivariable modeling.\"}]","Breast cancer surgery in the era of genetic uncertainty - real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance | PDF",1790136288,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a408a4985b500355e7a8a88c483e1be4.webp",983,1310,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74784d40f943ffe77b1682d0a4ef65e0.webp",982,1309,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c12c9c666b6c025fd2f41266dfce3462.webp",981,1308,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/393a5617ae11c0dc21512fa1c2c58bc8.webp",980,1306]